Effect of Imeglimin on mitochondrial function in patients with type 2 diabetes mellitus: a prospective cohort study
BackgroundImeglimin, a novel oral hypoglycemic agent, is known to influence mitochondrial function and glucose metabolism. This study evaluates its effects on glycemic control, mitochondrial DNA (mtDNA) copy number, and telomere dynamics in type 2 diabetes mellitus (T2DM).MethodsType 2 diabetes mell...
Saved in:
| Main Authors: | Abhishek Satheesan, Janardanan Kumar, Kakithakara Vajravelu Leela, Ria Murugesan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Endocrinology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2025.1585834/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gastrointestinal symptoms in patients receiving imeglimin in combination with metformin: A post‐hoc analysis of imeglimin clinical trial data
by: Jumpei Ito, et al.
Published: (2025-04-01) -
Evaluation of Efficacy, Safety, and Tolerability of Imeglimin Hydrochloride SR Tablets 1000 mg in Participants with Inadequately Controlled Type 2 Diabetes Mellitus: A Phase III, Randomized, Double-Blind, Active-Controlled, Parallel Group, Multicenter Clinical Study from India
by: Prashant Kumthekar, et al.
Published: (2025-04-01) -
Food order affects blood glucose and insulin levels in women with gestational diabetes
by: Ria Murugesan, et al.
Published: (2024-12-01) -
Imeglimin Halts Liver Damage by Improving Mitochondrial Dysfunction in a Nondiabetic Male Mouse Model of Metabolic Dysfunction-Associated Steatohepatitis
by: Kosuke Kaji, et al.
Published: (2024-11-01) -
Multistrain Probiotics and Telomere Length in Type 2 Diabetes: A 24-Week Randomized Controlled Trial
by: Venkata Chaithanya, et al.
Published: (2025-02-01)